AtG Therapeutics completes a seed financing round raising more than half a million euros.

AtG Therapeutics is a recently created spin-off from IDIBELL and ICO, announces its launch with a first round of financing collecting 556,000 euros, received the support of international and national entities, including Blue Goose Capital, Women Angels for STEAM (WA4STEAM), the StapleCat/Inveniam group, and renowned international scientists.

AtG Therapeutics has been founded by researchers Oriol Casanovas and Gabriela Jiménez, with international advisor Bart Huisken, AtG Therapeutics will develop a portfolio of drugs for advanced cancer treatment. The company has a team with extensive consolidated experience in the pharmaceutical and biotechnology industry.